A promoter polymorphism (−839 C > T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children
- 16 October 2006
- journal article
- research article
- Published by Wiley in American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics
- Vol. 144B (2), 215-219
- https://doi.org/10.1002/ajmg.b.30428
Abstract
The dopamine transporter (DAT) plays a key role in the regulation of dopaminergic neurotransmission and is also the major site of action for methylphenidate which is one of the main drugs used to treat attention deficit hyperactivity disorder (ADHD). Most association studies with ADHD have concentrated on the 3′-untranslated region of the gene (3′-UTR) mainly in a variable number of tandem repeat (VNTR) polymorphism, but these investigations have reported discordant results. In this study, we tested this VNTR polymorphism and an additional promoter polymorphism −839 C>T (Rs: 2652511) using family-based association analyses in a sample of 243 Brazilian ADHD children and adolescents and their parents. No significant linkage disequilibrium between the two polymorphisms was detected in this sample (D′ = 0.56; P = 0.22). No evidence of association with the VNTR polymorphism was found. A significant association (P = 0.03) for biased transmission of the C allele at the −839 C>T polymorphism to ADHD children in the total sample was observed, which was strengthened when the analyses were restricted to the ADHD combined type (P = 0.004). Our results suggest a role for the promoter region of DAT1 gene in ADHD susceptibility in this Brazilian sample.Keywords
This publication has 55 references indexed in Scilit:
- Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samplesMolecular Psychiatry, 2005
- Sequence variation in the 3′‐untranslated region of the dopamine transporter gene and attention‐deficit hyperactivity disorder (ADHD)American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2005
- Dopamine transporter haplotype and attention-deficit hyperactivity disorderMolecular Psychiatry, 2005
- The dopamine transporter: role in neurotoxicity and human diseaseToxicology and Applied Pharmacology, 2005
- Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT‐1 in striatum of asymptomatic volunteers and patients with Parkinson's diseaseMovement Disorders, 2003
- The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sampleMolecular Psychiatry, 2003
- Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT‐PCRAmerican Journal of Medical Genetics, 2002
- Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expressionMolecular Psychiatry, 2002
- A Generalization of the Transmission/Disequilibrium Test for Uncertain-Haplotype TransmissionAmerican Journal of Human Genetics, 1999
- Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTRGenomics, 1992